134 157

Cited 0 times in

Immunotherapy in Pancreatic Cancer; the Road Less Traveled

Authors
 Galam Leem  ;  Si Young Song 
Citation
 Immunological Disorders & Immunotherapy, Vol.1(2) : 1000106, 2016 
Journal Title
 Immunological Disorders & Immunotherapy 
Issue Date
2016
Abstract
Pancreatic cancer shows extremely low responses to chemo- and radiation therapies due to its inherent genetic instability, immunosuppressive microenvironment, and the complex peritumoral stroma. They make the pancreatic cancer most lethal malignancy with 5 year survival of less than 6%, so the need of new therapeutic approaches is urgently demanded. Immunotherapies have shown promises in other multiple cancers by augmenting anti-tumor immunity, so it stood out for the alternative care of pancreatic cancer. However, up to now, immunotherapeutic agents lack efficacy in pancreatic cancer. In this review, we give an overview of immune-related therapeutic strategies, clinical trials in pancreatic cancer and current obstacles that we face. We discuss the ways to overcome those current obstacles here, and by getting over them, we hope to get over the poor prognosis of pancreatic cancer.
Files in This Item:
T201605913.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Song, Si Young(송시영) ORCID logo https://orcid.org/0000-0002-1417-4314
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/153011
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links